Concepedia

Pablo Colorado

PC

12

Publications

2.7K

Citations

12

H-Index

2000

Active since

Affiliations

Bayer (Germany)(Current)

Harvard University Press

Imperial College London

Medizinische Hochschule Hannover

Universities of Giessen and Marburg Lung Center

Pablo Colorado is an author at Bayer (Germany) specializing in medicine, public health, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2000–2022

12

Publications

12

Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth

George D. Kamphaus, Pablo Colorado, David J. Panka et al. · Journal of Biological Chemistry · 2000 · 472 citations · Full text

Anti-angiogenic cues from vascular basement membrane collagen.

Pablo Colorado, Adriana de la Torre, George D. Kamphaus et al. · PubMed · 2000 · 423 citations

, , +19

Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane

Yohei Maeshima, Pablo Colorado, Adriana de la Torre et al. · Journal of Biological Chemistry · 2000 · 349 citations · Full text

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)

Gérald Simonneau, Andrea Maria D’Armini, Hossein Ardeschir Ghofrani et al. · European Respiratory Journal · 2014 · 305 citations · Full text

, , +18

Renal Fibrosis

Michael Zeisberg, Gary D. Bonner, Yohei Maeshima et al. · American Journal Of Pathology · 2001 · 293 citations · Full text

Rows per page

1–5 of 12